Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Other Working Capital Changes (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Other Working Capital Changes readings, the most recent being -$636000.0 for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes fell 179.3% to -$636000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $619000.0, a 65.8% decrease, with the full-year FY2025 number at $17375.0, down 18.83% from a year prior.
  • Other Working Capital Changes hit -$636000.0 in Q4 2025 for Arcadia Biosciences, down from $16525.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $802000.0 in Q4 2024 to a low of -$636000.0 in Q4 2025.
  • Median Other Working Capital Changes over the past 5 years was $14550.5 (2024), compared with a mean of $43006.2.
  • Biggest five-year swings in Other Working Capital Changes: soared 5888.57% in 2024 and later tumbled 6759.21% in 2025.
  • Arcadia Biosciences' Other Working Capital Changes stood at -$508000.0 in 2021, then skyrocketed by 223.43% to $627000.0 in 2022, then dropped by 8.77% to $572000.0 in 2023, then skyrocketed by 40.21% to $802000.0 in 2024, then tumbled by 179.3% to -$636000.0 in 2025.
  • The last three reported values for Other Working Capital Changes were -$636000.0 (Q4 2025), $16525.0 (Q3 2025), and $16525.0 (Q2 2025) per Business Quant data.